These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28574446)

  • 1. Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model".
    Purba ER; Saita EI; Maruyama IN
    Cells; 2017 Jun; 6(2):. PubMed ID: 28574446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain.
    Moriki T; Maruyama H; Maruyama IN
    J Mol Biol; 2001 Aug; 311(5):1011-26. PubMed ID: 11531336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric activation of preformed EGF receptor dimers by a single ligand binding event.
    Purba ER; Saita EI; Akhouri RR; Öfverstedt LG; Wilken G; Skoglund U; Maruyama IN
    Front Endocrinol (Lausanne); 2022; 13():1042787. PubMed ID: 36531494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.
    Yu X; Sharma KD; Takahashi T; Iwamoto R; Mekada E
    Mol Biol Cell; 2002 Jul; 13(7):2547-57. PubMed ID: 12134089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural perspective on the regulation of the epidermal growth factor receptor.
    Kovacs E; Zorn JA; Huang Y; Barros T; Kuriyan J
    Annu Rev Biochem; 2015; 84():739-64. PubMed ID: 25621509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of transmembrane cell-surface receptors via a common mechanism? The "rotation model".
    Maruyama IN
    Bioessays; 2015 Sep; 37(9):959-67. PubMed ID: 26241732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Ligand-Induced Dimerization is Sufficient to Initiate the Signalling and Endocytosis of EGF Receptor.
    Kourouniotis G; Wang Y; Pennock S; Chen X; Wang Z
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27463710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive asymmetric dimerization drives oncogenic activation of epidermal growth factor receptor carboxyl-terminal deletion mutants.
    Park AK; Francis JM; Park WY; Park JO; Cho J
    Oncotarget; 2015 Apr; 6(11):8839-50. PubMed ID: 25826094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand binding induces a conformational change in epidermal growth factor receptor dimers.
    Walker F; Rothacker J; Henderson C; Nice EC; Catimel B; Zhang HH; Scott AM; Bailey MF; Orchard SG; Adams TE; Liu Z; Garrett TP; Clayton AH; Burgess AW
    Growth Factors; 2012 Dec; 30(6):394-409. PubMed ID: 23163584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
    Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
    ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor: association of extracellular domain negatively regulates intracellular kinase activation in the absence of ligand.
    Zhu HJ; Iaria J; Orchard S; Walker F; Burgess AW
    Growth Factors; 2003 Mar; 21(1):15-30. PubMed ID: 12795333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
    Kozer N; Kelly MP; Orchard S; Burgess AW; Scott AM; Clayton AH
    Biochemistry; 2011 May; 50(18):3581-90. PubMed ID: 21495621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J; Ma C; Huang Y; Luo J; Huang C
    Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Model for Epidermal Growth Factor Receptor Ligand Binding Involving Conformational States of the Extracellular and the Kinase Domains.
    Hajdu T; Váradi T; Rebenku I; Kovács T; Szöllösi J; Nagy P
    Front Cell Dev Biol; 2020; 8():776. PubMed ID: 32850868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the EGF receptor by insertional mutations in its juxtamembrane regions.
    Sorokin A
    Oncogene; 1995 Oct; 11(8):1531-40. PubMed ID: 7478577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells.
    Huang Y; Chang Y; Wang X; Jiang J; Frank SJ
    Endocrinology; 2004 Jul; 145(7):3297-306. PubMed ID: 15070853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
    Müller N; Hartmann C; Genssler S; Koch J; Kinner A; Grez M; Wels WS
    Int J Cancer; 2014 Jun; 134(11):2547-59. PubMed ID: 24243620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
    Tao RH; Maruyama IN
    J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
    Harding J; Burtness B
    Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.